Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial. 

Hernandez G, ANDROMEDA-SHOCK-2 Investigators for the ANDROMEDA Research Network JAMA. 2025 Oct 29:e2520402. doi: 10.1001/jama.2025.20402.

 

Editorial:

Capillary Refill Time in Sepsis-Searching for the Holy Grail.

Machado FR, et al. JAMA. 2025 Oct 29. doi: 10.1001/jama.2025.20518.

 

Methodology: 4.5/5
Usefulness: 4/5

 

Question and Methods: 1501 patients were randomized across 86 centres to a personalized resuscitation protocol vs. standard of care within 6 hours of septic shock to improves outcomes

Findings: The protocol was superior to usual care for the primary hierarchical composite outcome (Win ratio 1.16, 95% CI 1.04-1.28), though 28-day mortality was similar (26.5% vs. 26.6%).

Limitations: The study was unblinded, potentially introducing bias in clinical decision-making, and possible inter-rater variability in assessing capillary refill time across different sites

Interpretation: This suggests moving from a “one-size-fits-all” resuscitation to a personalized, physiology-guided approach to accelerate organ recovery.

 

 

Authors

  • Sam Wilson

    Dr. Wilson (Sam) is a first-year Emergency Medicine FRCPC resident at The Ottawa Hospital. Aside from EMOttawa, Sam works as the CanadiEM CJEM Infographic editor, and is interested in PoCUS, medical teaching, knowledge dissemination, and all things chess.

    View all posts
  • Dr. Venkatesh Thiruganasambandamoorthy is an attending physician and associate scientist at the Ottawa Hospital and Ottawa Hospital Research Institute with an particular interest in syncope and presyncope care.

    View all posts